0%
HCC Frontiers 2026 - Advancing the Management of Intermediate HCC. Live academic webinar on 15th July 2026 from 7:00 PM to 9:05 PM via Zoom.
HCC Frontiers 2026: Advancing the Management of Intermediate HCC is an educational live webinar held under the aegis of Academy of Cancer Care Foundation and Research Center (ACCFRC), Practice Events, and Keyson Healthcare. Featuring Dr. Ravikumar Wategaonkar (Consultant Medical Oncologist, M|O|C Cancer Care and Research Centre, Pune) and Chairperson Dr. Suresh Advani. Agenda features: First-Line Systemic Therapy in Unresectable HCC: Integrating Latest ASCO/ESMO Evidence by Dr. Ashwin Rajbhoj; Patient Selection & Sequencing Strategies for Immunotherapy Combinations by Dr. Nikhil Shirsi; Beyond Atezolizumab + Bevacizumab: Optimizing Treatment Pathways After Progression by Dr. Nilesh Dhamne; and Panel Discussion moderated by Dr. Tushar Patil with panelists Dr. Ashwin Rajbhoj, Dr. Nilesh Dhamne, Dr. Nikhil Shirsi, Dr. Ravikumar Wategaonkar, and Dr. Siddhesh Tryambake. Contact Sakshee (9152500322) or Udit (9004599174) for details.
The primary aim of HCC Frontiers 2026 is to deliver cutting-edge clinical evidence on patient selection, immunotherapy combinations, and post-progression sequencing strategies in intermediate and unresectable Hepatocellular Carcinoma (HCC).
The program was conducted as a structured virtual webinar & interactive online forum. The agenda included expert talks on ASCO/ESMO trial updates, second-line therapeutic pathways, and an interactive panel discussion with multidisciplinary liver cancer specialists.
The webinar established updated treatment algorithms for intermediate HCC management, emphasizing the role of Atezolizumab + Bevacizumab and optimal sequencing strategies to maximize clinical benefit and overall survival.